Drugs / Acne mRNA vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07013747 | Jul 2025 → Jun 2029 expected | acne | Sanofi Pasteur, a Sanofi Company | Recruiting | No outcome recorded |
| Phase 1/2 | NCT06316297 | Apr 2024 → Nov 2028 expected | acne | Sanofi Pasteur, a Sanofi Company | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acne mRNA vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06316297 ↗ |
| Modality | Messenger RNA (mRNA) | “Acne mRNA vaccine candidate” NCT06316297 ↗ |
| Route | Intramuscular | “Route of administration: intramuscular” NCT06316297 ↗ |